Following up on the whole discipline angle from the last post, it definitely seems like more is going to happen before there is either any legal action or baseball disciplinary action in the A-Rod case. I mean, last I checked we don’t prosecute people based on newspaper articles alone.
But what that next step is will be extremely interesting. Because it will tell us whether Major League Baseball and the DEA is more interested in drug users or drug dealers.
Back in the Mitchell Report days, MLB, George Mitchell and federal agents went to the drug dealers first and gave them various degrees of immunity. Why? Because no one cared about drug dealers. The Mitchell Report, as I wrote at length back in the day, was a public relations exercise and everyone involved wanted to get the names of PED-using players out in the open. The league wanted to look like it was taking action, George Mitchell wanted prestige and billable hours for his law firm and the feds wanted some big, celebrity heads on pikes. This, by the way, is a lot of the reason why the lowest hanging fruit was picked back then and guys like A-Rod and Biogenesis went unmentioned.
But what now? Once again we have MLB and the DEA pursuing PEDs. Based on the Miami New Times report, the next obvious move for law enforcement is to either get players like A-Rod, Nelson Cruz, Bartolo Colon, Gio Gonzalez and others in a room to talk about the clinic’s possibly illegal prescriptions or else to get the clinic’s operators in to talk about the users. That’s how the next phase of this has to go.
Will the DEA decide to pursue distributors or end users? Will MLB seek out the quickest means to get “just cause” suspension evidence on the players, or will it attempt to learn everything it can about what may very well be the biggest pipeline of drugs into its sport?
The choices that are made about all of this in the coming days will tell us a lot about the league’s and the feds’ priorities.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.
Mariners’ right-hander Arquimedes Caminero is nearing a deal with the Yomiuri Giants of Nippon Professional Baseball, according to Bob Dutton of the Tacoma News Tribune. The club has reportedly agreed to sell the 29-year-old’s contract, Dutton writes, though no official move has been announced by either team yet. Caminero is under club control through 2020 and currently ineligible for arbitration.
The right-hander began the 2016 season with the Pirates but was sent to the Mariners in a trade for Seattle minor leaguers Jake Brentz and Pedro Vasquez in order to clear space in the Bucs’ bullpen. With the Mariners, Caminero produced a 3.66 ERA and 8.2 K/9 through 19 2/3 innings in the second half of the year. Although he boasts an electric fastball, one which consistently averaged 98.7 m.p.h. in 2016, his success rate has been tempered by poor control throughout his major league career. According to Dutton, the Mariners’ willingness to sell Caminero’s contract was a strong indication that they did not see him as a viable contender for their 2017 bullpen or as a potential trade chip further down the line.
Should the deal go through, the right-hander will be the second former Mariner to sign with a Japanese club for the 2017 season. Per Dutton’s report, outfielder Stefen Romero also picked up a contract with the Orix Buffaloes of NPB in late November.